145
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease Among Users of Primary Health Care Facilities in Morocco

ORCID Icon, , , ORCID Icon, , ORCID Icon, , , , , , , & show all
Pages 375-387 | Received 04 Oct 2023, Accepted 26 Dec 2023, Published online: 09 Feb 2024

References

  • Celli B, Fabbri L, Criner G, et al. Definition and nomenclature of chronic obstructive pulmonary disease: time for its revision. Am J Respir Crit Care Med. 2022;206(11):1317–1325. doi:10.1164/rccm.202204-0671PP
  • Halpin DMG, Celli BR, Criner GJ, et al. The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries. Int J Tuberc Lung Dis. 2019;23(11):1131–1141. doi:10.5588/ijtld.19.0397
  • López-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21(1):14–23. doi:10.1111/resp.12660
  • Li X, Cao X, Guo M, et al. Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the global burden of disease study 2017. BMJ. 2020;368:m234. doi:10.1136/bmj.m234
  • Mahboub B, Alzaabi A, Iqbal MN, et al. Comorbidities associated with COPD in the Middle East and North Africa region: association with severity and exacerbations. Int J Chron Obstruct Pulmon Dis. 2016;11:273–280. doi:10.2147/COPD.S90626
  • Iheanacho I, Zhang S, King D, et al. Economic burden of Chronic Obstructive Pulmonary Disease (COPD): a systematic literature review. Int J Chron Obstruct Pulmon Dis. 2020;15:439–460. doi:10.2147/COPD.S234942
  • Adeloye D, Chua S, Lee C, et al; Global Health Epidemiology Reference Group (GHERG). Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015;5(2):020415. doi:10.7189/jogh.05.020415
  • Varmaghani M, Dehghani M, Heidari E, et al. Global prevalence of chronic obstructive pulmonary disease: systematic review and meta-analysis. East Mediterr Health J. 2019;25(1):47–57. doi:10.26719/emhj.18.014
  • Brandsma CA, de Vries M, Costa R, et al. Lung ageing and COPD: is there a role for ageing in abnormal tissue repair? Eur Respir Rev. 2017;26(146):170073. doi:10.1183/16000617.0073-2017
  • Wang C, Xu J, Yang L, et al.; China Pulmonary Health Study Group. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/S0140-6736(18)30841-9
  • Yang IA, Jenkins CR, Salvi SS. Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment. Lancet Respir Med. 2022;10(5):497–511. doi:10.1016/S2213-2600(21)00506-3
  • Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374(9691):733–743. doi:10.1016/S0140-6736(09)61303-9
  • Wheatley JR. Spirometry: key to the diagnosis of respiratory disorders. Med J Aust. 2017;207(10):422–423. doi:10.5694/mja17.00684
  • Kaplan A, Thomas M. Screening for COPD: the gap between logic and evidence. Eur Respir Rev. 2017;26(143):160113. doi:10.1183/16000617.0113-2016
  • Heffler E, Crimi C, Mancuso S, et al. Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients. Respir Med. 2018;142:48–52. doi:10.1016/j.rmed.2018.07.015
  • Joo MJ, Sharp LK, Au DH, et al. Use of spirometry in the diagnosis of COPD: a qualitative study in primary care. COPD. 2013;10(4):444–449. doi:10.3109/15412555.2013.766683
  • El Rhazi K, Nejjari C, BenJelloun MC, et al. Prevalence of chronic obstructive pulmonary disease in Fez, Morocco: results from the BOLD study. Int J Tuberc Lung Dis. 2016;20(1):136–141. doi:10.5588/ijtld.15.0029
  • Tobacco in facts and figures; 2013. Available from https://www.contrelecancer.ma/en/le_tabac_en_chiffres. Accessed January 17, 2024.
  • Harch I, Ben Maamar S, Nejjari C, et al. Exposure to Biomass and the Risk of COPD in Moroccan Women in the Region of Fes Cross-Sectional Study. Am J Respir Crit Care Med. 2021;203:A3157.
  • World Health Organization. Waist Circumference and Waist-to-Hip Ratio: Report of a WHO Expert Consultation, Geneva, December 8–11, 2008. Geneva: World Health Organization; 2011.
  • Bestall J, Paul E, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:7.
  • Laraqui O, Hammouda R, Laraqui S, et al. Prevalence of chronic obstructive respiratory diseases amongst fishermen. Int Marit Health. 2018;69(1):13–21. doi:10.5603/IMH.2018.0003
  • Crapo RO, Hankinson JL, Irvin C, et al. Standardization of Spirometry: 1994 Update. Am J Respir Crit Care Med. 1995;152(3):1107–1136. doi:10.1164/ajrccm.152.3.7663792
  • Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Eur Respir J. 2017;49(3):1700214. doi:10.1183/13993003.00214-2017
  • Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179–187. doi:10.1164/ajrccm.159.1.9712108
  • Su J, Ye Q, Zhang D, et al. Joint association of cigarette smoking and PM2.5 with COPD among urban and rural adults in regional China. BMC Pulm Med. 2021;21(1):87. doi:10.1186/s12890-021-01465-y
  • Leung C, Bourbeau J, Sin DD, et al; CanCOLD Collaborative Research Group. The Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and the Heterogeneity of Risk Factors in the Canadian Population: results from the Canadian Obstructive Lung Disease (COLD) Study. Int J Chron Obstruct Pulmon Dis. 2021;16:305–320. doi:10.2147/COPD.S285338
  • GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691–706. doi:10.1016/S2213-2600(17)30293-X
  • Sheng W, Huang Y, Deng Z, et al. Investigation of the prevalence and diagnosis of chronic obstructive pulmonary disease in a group of elderly individuals residing in an Island Area of Ningbo. Can Respir J. 2019;2019:6918340. doi:10.1155/2019/6918340
  • Kim SJ, Lee J, Park YS, et al. Age-related annual decline of lung function in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2015;11:51–60. doi:10.2147/COPD.S95028
  • Torrelles JB, Restrepo BI, Bai Y, et al. The impact of aging on the lung alveolar environment, predetermining susceptibility to respiratory infections. Front Aging. 2022;3:818700. doi:10.3389/fragi.2022.818700
  • Wheaton AG, Liu Y, Croft JB, et al. Chronic obstructive pulmonary disease and smoking status - United States, 2017. MMWR Morb Mortal Wkly Rep. 2019;68(24):533–538. doi:10.15585/mmwr.mm6824a1
  • Llordés M, Jaén A, Almagro P, et al. Prevalence, risk factors and diagnostic accuracy of COPD among smokers in primary care. COPD. 2015;12(4):404–412. doi:10.3109/15412555.2014.974736
  • Song Q, Chen P, Liu XM. The role of cigarette smoke-induced pulmonary vascular endothelial cell apoptosis in COPD. Respir Res. 2021;22(1):39. doi:10.1186/s12931-021-01630-1
  • Denguezli M, Daldoul H, Harrabi I, et al. COPD in nonsmokers: reports from the tunisian population-based burden of obstructive lung disease study. PLoS One. 2016;11(3):e0151981. doi:10.1371/journal.pone.0151981
  • Kumar K, Gupta PP, Verma AK, et al. Assessment of prevalence and characteristics of asthma-COPD overlap among patients with chronic airflow obstruction. Monaldi Arch Chest Dis. 2022;93(2). doi:10.4081/monaldi.2022.2323
  • Fang L, Gao P, Bao H, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study. Lancet Respir Med. 2018;6(6):421–430. doi:10.1016/S2213-2600(18)30103-6
  • Benslimane A, Garcia-Larsen V, El Kinany K, et al. Association between obesity and chronic obstructive pulmonary disease in Moroccan adults: evidence from the BOLD study. SAGE Open Med. 2021;9:20503121211031428. doi:10.1177/20503121211031428
  • Atassi M, Kava ACF, Nejjari C, et al. Association between chronic airflow obstruction and socio-economic position in Morocco: BOLD results. Int J Tuberc Lung Dis. 2020;24(2):202–206. doi:10.5588/ijtld.19.0170
  • Lamprecht B, Soriano JB, Studnicka M, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015;148(4):971–985. doi:10.1378/chest.14-2535
  • Yu WC, Fu SN, Tai EL, et al. Spirometry is underused in the diagnosis and monitoring of patients with chronic obstructive pulmonary disease (COPD). Int J Chron Obstruct Pulmon Dis. 2013;8:389–395. doi:10.2147/COPD.S48659
  • Melbye H, Stylidis M, Solis JCA, et al. Prediction of chronic heart failure and chronic obstructive pulmonary disease in a general population: the Tromsø study. ESC Heart Fail. 2020;7(6):4139–4150. doi:10.1002/ehf2.13035
  • Kim CY, Kim BK, Kim YJ, et al. Longitudinal evaluation of the relationship between low socioeconomic status and incidence of chronic obstructive pulmonary disease: Korean Genome and Epidemiology Study (KoGES). Int J Chron Obstruct Pulmon Dis. 2021;15:3447–3454. doi:10.2147/COPD.S276639
  • Bikbov MM, Kazakbaeva GM, Zainullin RM, et al. Prevalence, awareness, and associated factors of airflow obstruction in Russia: the ural eye and medical study. Front Public Health. 2019;7:350. doi:10.3389/fpubh.2019.00350
  • Doiron D, de Hoogh K, Probst-Hensch N, et al. Air pollution, lung function and COPD: results from the population-based UK Biobank study. Eur Respir J. 2019;54(1):1802140. doi:10.1183/13993003.02140-2018